Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Dr. Sherif Abdou F.A.C.E.P., FACP, M.D.

Market Cap

NaN undefined USD

Sector

Healthcare

Website

https://p3hp.org

Description

P3 Health Partners Inc.

Read More

Overview

Value

0

Growth

21

Health

23

Management

70

Analyst Opinion

0

Total

38

All Scores Out Of 100

Best Features

  • Earnings growth has improved recently
  • Has a low level of debt
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Earnings are negative
  • Does not hold enough liquid assets to cover short term liabilities
  • Poor overall financial health
  • Poor earnings and cashflow growth
  • Accounting anomalies: Growing revenues without a corresponding growth in cash flows.
  • 0

Market Peers

PIIIW

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

N/A

Revenue Growth (5 Year Average)

3.58%

Ratings Consensus

N/A

Share Buybacks

N/A

Dividend Yeild (TTM)

N/A

Valuation

Value Score

0

  • Estimated intrinsic-value of N/A is lower than current price ( 327.50 undefined USD)
  • Free-cashflow-yeild of N/A is worse than the market average (4.7%)
  • Margin-of-safety of N/A is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/ANaNNaN

Current Price: 0.3 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

N/A

PE/Earnings Growth

N/A

Price/Book

Infinityx

Growth

Growth Score

21

  • Revenue growth has improved this yeara
  • Earnings growth has improved this year
  • 5 Year Average Revenue growth of 3.58% is lower than the market average (10.97%)
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
  • 5 Year Average Free Cashflow growth of -2.00% is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

3.58%

Earnings Growth

N/A

Cashflow Growth

-2.00%

Health

Health Score

23

  • Has a low level of debt
  • Assets do not cover liabilities
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

N/A

Piostroski Score

N/A

Debt/Equity

N/Ax

Current Assets/Liabilities

0.40x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

1.12x

Management

Management Score

70

  • Return-on-capital-employed of -0.49% is lower than the market average (10%)
  • Return-on-equity of N/A is lower than the market average (15%)

Average Buybacks/Dilution

N/A

Recent Buybacks/Dilution

-100.00%

5 Year Price Volitility

53.27%

Return On Assets

N/A

Return On Capital Employed

-0.49%

Return On Equity

N/A

Return On Free Cashflow

N/A

Return On Investments

N/A

Analysts

Analyst Opinion

0

    SEC Filings

    Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

    Other Information

    Company Name

    P3 Health Partners Inc.

    Currency

    USD

    Beta

    0

    Vol Avg

    0

    Ceo

    Dr. Sherif Abdou F.A.C.E.P., FACP, M.D.

    Cik

    0001832511

    Cusip

    744413113

    Exchange

    NASDAQ Global Market

    Full Time Employees

    392

    Industry

    Medical Care Facilities

    Sector

    Healthcare

    Ipo Date

    2021-12-03

    Address

    2370 Corporate Circle

    City

    Henderson

    State

    NV

    Country

    US

    Zip

    89074

    Phone

    702-910-3950

    All financial data provided by FMP

    Noticed an error with something on our site?

    We Use Cookies